Detalhe da pesquisa
1.
Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(8): 995-1008, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798016
2.
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade.
Br J Cancer
; 126(4): 569-575, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34621044
3.
Cabozantinib in combination with atezolizumab versus sorafenib in treatment-naive advanced hepatocellular carcinoma: COSMIC-312 Phase III study design.
Future Oncol
; 16(21): 1525-1536, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32491932
4.
AI-supported modified risk staging for multiple myeloma cancer useful in real-world scenario.
Transl Oncol
; 14(9): 101157, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34247136
5.
Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer.
J Transl Med
; 6: 38, 2008 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-18644162
6.
Fat paradox of steatohepatitis.
J Gastroenterol Hepatol
; 23 Suppl 1: S104-7, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18336651
7.
Ciglitazone mediates COX-2 dependent suppression of PGE2 in human non-small cell lung cancer cells.
Prostaglandins Leukot Essent Fatty Acids
; 77(1): 51-8, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17697767
8.
Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer.
Clin Lung Cancer
; 7(1): 30-9, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16098242
9.
PPAR Gamma and Hepatic Stellate Cells.
Comp Hepatol
; 3 Suppl 1: S7, 2004 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-14960159
10.
Loss of miR125a expression in a model of K-ras-dependent pulmonary premalignancy.
Cancer Prev Res (Phila)
; 7(8): 845-55, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24913817
11.
Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer.
Sci Signal
; 7(318): ra29, 2014 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-24667376
12.
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer.
Sci Transl Med
; 5(196): 196ra99, 2013 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-23903756
13.
PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer.
Am J Transl Res
; 2(4): 356-67, 2010 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20733946
14.
Proinflammatory mediators upregulate snail in head and neck squamous cell carcinoma.
Clin Cancer Res
; 15(19): 6018-27, 2009 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19789323
15.
The Role of PPARgamma in the Cyclooxygenase Pathway in Lung Cancer.
PPAR Res
; 2008: 790568, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18769553
16.
Pioglitazone and rosiglitazone decrease prostaglandin E2 in non-small-cell lung cancer cells by up-regulating 15-hydroxyprostaglandin dehydrogenase.
Mol Pharmacol
; 71(6): 1715-20, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17412838
17.
Inflammation and lung carcinogenesis: applying findings in prevention and treatment.
Expert Rev Anticancer Ther
; 7(10): 1405-21, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17944566
18.
Anti-adipogenic regulation underlies hepatic stellate cell transdifferentiation.
J Gastroenterol Hepatol
; 21 Suppl 3: S102-5, 2006 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16958658
19.
Adipogenic transcriptional regulation of hepatic stellate cells.
J Biol Chem
; 280(6): 4959-67, 2005 Feb 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-15537655
20.
Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells.
J Biol Chem
; 279(12): 11392-401, 2004 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-14702344